Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1980 1
1983 1
1986 1
1987 2
1989 4
1990 3
1991 6
1992 3
1994 3
1995 7
1996 13
1997 9
1998 8
1999 9
2000 12
2001 13
2002 8
2003 13
2004 6
2005 3
2006 5
2007 12
2008 9
2009 12
2010 11
2011 10
2012 13
2013 11
2014 14
2015 10
2016 15
2017 18
2018 14
2019 15
2020 12
2021 17
2022 21
2023 20
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Results by year

Filters applied: . Clear all
Page 1
The epidemiology of amyotrophic lateral sclerosis.
Talbott EO, Malek AM, Lacomis D. Talbott EO, et al. Handb Clin Neurol. 2016;138:225-38. doi: 10.1016/B978-0-12-802973-2.00013-6. Handb Clin Neurol. 2016. PMID: 27637961 Review.
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults and is characterized by neurodegeneration of motor neurons in the brain and spinal cord. The incidence of ALS is approximately 1-2.6 cases …
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults and is chara …
Rehabilitation in amyotrophic lateral sclerosis: why it matters.
Majmudar S, Wu J, Paganoni S. Majmudar S, et al. Muscle Nerve. 2014 Jul;50(1):4-13. doi: 10.1002/mus.24202. Epub 2014 May 17. Muscle Nerve. 2014. PMID: 24510737 Free PMC article. Review.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that results in a constellation of problematic symptoms and a high patient and caregiver burden. ...At each disease stage, an experienced rehabilitation team is well positioned to …
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that results in a constellation of problematic …
Spinal muscular atrophy.
D'Amico A, Mercuri E, Tiziano FD, Bertini E. D'Amico A, et al. Orphanet J Rare Dis. 2011 Nov 2;6:71. doi: 10.1186/1750-1172-6-71. Orphanet J Rare Dis. 2011. PMID: 22047105 Free PMC article. Review.
Estimated incidence is 1 in 6,000 to 1 in 10,000 live births and carrier frequency of 1/40-1/60. ...This disease is caused by homozygous mutations of the survival motor neuron 1 (SMN1) gene, and the diagnostic test demonstra …
Estimated incidence is 1 in 6,000 to 1 in 10,000 live births and carrier frequency of 1/40-1/60. ...This dise …
Circuit Mechanisms of Parkinson's Disease.
McGregor MM, Nelson AB. McGregor MM, et al. Neuron. 2019 Mar 20;101(6):1042-1056. doi: 10.1016/j.neuron.2019.03.004. Neuron. 2019. PMID: 30897356 Free article. Review.
The second most common neurodegenerative disorder after Alzheimer's disease, it affects approximately 1% of adults over age 60. Diagnosis follows the development of one or more of the core motor features of the disease, including tremor, slowing …
The second most common neurodegenerative disorder after Alzheimer's disease, it affects approximately 1% of adults over …
Occupational Therapy Interventions in Adults with Multiple Sclerosis or Amyotrophic Lateral Sclerosis: A Scoping Review.
De-Bernardi-Ojuel L, Torres-Collado L, García-de-la-Hera M. De-Bernardi-Ojuel L, et al. Int J Environ Res Public Health. 2021 Feb 3;18(4):1432. doi: 10.3390/ijerph18041432. Int J Environ Res Public Health. 2021. PMID: 33546507 Free PMC article. Review.
This scoping review aims to describe occupational therapy interventions carried out with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) patients in occupational therapy. ...A search of the literature published was carried out before December …
This scoping review aims to describe occupational therapy interventions carried out with multiple sclerosis (MS) and amyotrophic l …
Tofersen: First Approval.
Blair HA. Blair HA. Drugs. 2023 Jul;83(11):1039-1043. doi: 10.1007/s40265-023-01904-6. Drugs. 2023. PMID: 37316681 Review.
Tofersen (Qalsody()) is an antisense oligonucleotide being developed by Biogen for the treatment of amyotrophic lateral sclerosis (ALS). On 25 April 2023, tofersen was approved in the USA for the treatment of ALS in adults who have a mutation in the superoxid …
Tofersen (Qalsody()) is an antisense oligonucleotide being developed by Biogen for the treatment of amyotrophic lateral sclerosis …
Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.
Schorling DC, Pechmann A, Kirschner J. Schorling DC, et al. J Neuromuscul Dis. 2020;7(1):1-13. doi: 10.3233/JND-190424. J Neuromuscul Dis. 2020. PMID: 31707373 Free PMC article. Review.
Spinal Muscular Atrophy (SMA) is caused by autosomal recessive mutations in SMN1 and results in the loss of motor neurons and progressive muscle weakness. The spectrum of disease severity ranges from early onset with respiratory failure during the first months of li …
Spinal Muscular Atrophy (SMA) is caused by autosomal recessive mutations in SMN1 and results in the loss of motor neurons and progres …
Amyotrophic lateral sclerosis.
Wijesekera LC, Leigh PN. Wijesekera LC, et al. Orphanet J Rare Dis. 2009 Feb 3;4:3. doi: 10.1186/1750-1172-4-3. Orphanet J Rare Dis. 2009. PMID: 19192301 Free PMC article. Review.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by progressive muscular paralysis reflecting degeneration of motor neurones in the primary motor cortex, corticospinal tracts, brainstem and spinal cord. ... …
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by progressive muscular paralysis refl …
Neuromuscular diseases: Diagnosis and management.
Mary P, Servais L, Vialle R. Mary P, et al. Orthop Traumatol Surg Res. 2018 Feb;104(1S):S89-S95. doi: 10.1016/j.otsr.2017.04.019. Epub 2017 Nov 28. Orthop Traumatol Surg Res. 2018. PMID: 29196274 Free article. Review.
The main NMDs relevant to the orthopaedic surgeon are infantile spinal muscular atrophy (a motor neuron disease), peripheral neuropathies (chiefly, Charcot-Marie-Tooth disease), congenital muscular dystrophies, progressive muscular dystrophies, and Ste …
The main NMDs relevant to the orthopaedic surgeon are infantile spinal muscular atrophy (a motor neuron disease), perip …
State of play in amyotrophic lateral sclerosis genetics.
Renton AE, Chiò A, Traynor BJ. Renton AE, et al. Nat Neurosci. 2014 Jan;17(1):17-23. doi: 10.1038/nn.3584. Epub 2013 Dec 26. Nat Neurosci. 2014. PMID: 24369373 Free PMC article. Review.
Considerable progress has been made in unraveling the genetic etiology of amyotrophic lateral sclerosis (ALS), the most common form of adult-onset motor neuron disease and the third most common neurodegenerative disease overall. He …
Considerable progress has been made in unraveling the genetic etiology of amyotrophic lateral sclerosis (ALS), the most common …
339 results